#nasdaq:sbbp

Analyst Activity – JMP Securities Reiterates Outperform on Strongbridge Biopharma (NASDAQ:SBBP)

Analyst Ratings For Strongbridge Biopharma (NASDAQ:SBBP) Today, JMP Securities reiterated its Outperform rating on Strongbridge Biopharma (NASDAQ:SBBP). There are 3 buy ratings on the stock. The current consensus rating on Strongbridge Biopharma (NASDAQ:SBBP) is Buy (Score: 3.00) with a consensus target price of $13.50 per share, a potential 486.96% upside. Some recent analyst ratings include…